{"id":9004111222090539,"date":"2021-05-20T10:08:25","date_gmt":"2021-05-20T09:08:25","guid":{"rendered":"https:\/\/www.hgf.com\/?p=9004111222090539"},"modified":"2026-02-12T14:09:17","modified_gmt":"2026-02-12T14:09:17","slug":"webinar-developing-effective-patent-strategies-for-personalised-medical-devices-in-europe-and-the-us","status":"publish","type":"post","link":"https:\/\/www.hgf.com\/de\/knowledge-hub\/events\/webinar-developing-effective-patent-strategies-for-personalised-medical-devices-in-europe-and-the-us\/","title":{"rendered":"Webinar: Developing effective patent strategies for personalised medical devices in Europe and the US"},"content":{"rendered":"

HGF in Europe and Knobbe Martens<\/a> in the US are holding a joint webinar on 9th June.<\/p>\n

In this webinar we will explore considerations for implementing an effective strategy to secure patent protection for personalised medical devices, and to steer through a potentially crowded competitive landscape, with a particular focus on comparing the European and US jurisdictions.<\/p>\n

The emergence of new platform technologies directed to patient-specific healthcare solutions has led to significant investment and R&D associated with personalised medical devices. In order to protect their technological innovations, many companies are striving to strategically develop global patent portfolios that support the commercialisation of their products and which can leverage a dominant commercial position over competitors. As national and regional differences exist between legal provisions that govern intellectual property, it is not always possible to adopt a \u201cone-size-fits-all\u201d approach. A more thorough understanding of these differences is therefore vital when seeking to maximise the scope of protection available to the patent proprietor or to minimise patent infringement risk when commercialising personalised medical devices.<\/p>\n

This webinar will cover:<\/p>\n